Home Market News Micro Cap Stocks Massive Surge in RayzeBio Stock Leaves Investors Shaken

Massive Surge in RayzeBio Stock Leaves Investors Shaken

Massive Surge in RayzeBio Stock Leaves Investors Shaken

RayzeBio, Inc. RYZB found itself skyrocketing to dizzying heights on Tuesday after the news of its acquisition by Bristol Myers Squibb for $62.50 per share in cash. This earth-shattering deal is valued at $4.1 billion – a hefty chunk of change by anyone’s standards.

On Tuesday, RayzeBio shares rocketed up by a staggering 100% to reach $61.38, leaving both investors and industry analysts stunned by the sudden leap.

The stock market was abuzz with other notable upswings as well.


  • ARB IOT Group Limited ARBB saw a colossal 270% surge, reaching $3.4850 after already gaining 18% on Friday.
  • IMAC Holdings, Inc. BACK witnessed a remarkable 108% jump to $5.05, following a 53% increase on Friday.
  • Inspira Technologies Oxy B.H.N. Ltd. IINN shot up by 75% to $2.0988 after announcing 95% accuracy for the HYLA blood sensor.
  • Gracell Biotechnologies Inc. GRCL experienced a substantial 60.3% increase, reaching $9.92 following AstraZeneca’s plans to acquire Gracell Biotechnologies for up to $1.2 billion.
  • Science 37 Holdings, Inc. SNCE leaped 52% to $6.62 after receiving notification from Nasdaq that the company had regained compliance with the minimum closing bid price requirement for continued listing.
  • Volcon, Inc. VLCN rose a substantial 49.8% to $0.1483, following a 24% increase on Friday.
  • Sight Sciences, Inc. SGHT gained 48.9% to $5.42.
  • AERWINS Technologies Inc.AWIN surged by 36.4% to $0.1637 after entering into a letter of intent to form an entity with Helicopter Technology, with 70% ownership for AERWINS Technologies Inc. and 30% for Helicopter Technology.
  • SCWorx Corp. WORX climbed 32% to $2.3349 following the announcement of a definitive agreement and plan of merger with American Environmental Partners.
  • 60 Degrees Pharmaceuticals, Inc. SXTP rose 30% to $1.1750 after announcing IRB approval for its Phase IIA clinical study to evaluate tafenoquine for babesiosis.

Carnage on the Market Floor: Investors Left Spinning as Stocks Take a Dive

  • Prospector Capital Corp. LDTC shares fell 30.3% to $2.9218 after jumping around 77% on Friday.
  • NextPlay Technologies, Inc. NXTP shares fell 23.8% to $2.08 after surging over 200% on Friday.
  • ENDRA Life Sciences Inc. NDRA fell 23.6% to $1.91.
  • Esports Entertainment Group, Inc. GMBL dipped 23.6% to $5.28.
  • Banzai International, Inc. BNZI declined 20.7% to $2.75.
  • Adit EdTech Acquisition Corp. ADEX shares fell 20.6% to $3.9801. Adit EdTech Acquisition announced intention to voluntarily de-list from NYSE American.
  • Know Labs, Inc. KNW dipped 19.2% to $0.47. Know Labs filed for mixed shelf of up to $18 million.
  • Turbo Energy, S.A. TURB fell 19% to $1.23.
  • Starbox Group Holdings Ltd. STBX declined 16.2% to $0.2599.
  • Jin Medical International Ltd. ZJYL fell 15.7% to $116.94 after jumping 94% on Friday.
  • ZIM Integrated Shipping Services Ltd. ZIM declined 15.2% to $9.82.
  • Vroom, Inc. VRM shares fell 14.5% to $0.6295. Vroom filed a preliminary proxy statement with the SEC regarding a special stockholders’ meeting to be held on Feb. 5, 2024 to effect a reverse stock split of the company’s common stock at an exchange ratio between 1-for-35 to 1-for-80.
  • NeoVolta Inc. NEOV fell 14.4% to $1.54.
  • Journey Medical Corporation DERM dipped 13.8% to $6.86.
  • Asset Entities Inc. ASST fell 13.4% to $0.6907 after surging 21% on Friday.
  • Enlivex Therapeutics Ltd. ENLV fell 11% to $2.57.
  • FlexShopper, Inc. FPAY fell 9.5% to $1.6191.
  • BTC Digital Ltd. BTCT fell 9.3% to $4.08. BTC Digital announced entry into $1.014 million share subscription agreements in connection with private placement of ordinary shares for the issue and sale of 303,497 ordinary shares of the company, par value $0.06 per share.
  • Oncternal Therapeutics, Inc. ONCT fell 8% to $0.55. Oncternal Therapeutics updated the status of a recent study involving a treatment for relapsed or refractory aggressive B-cell lymphoma, including patients who have failed previous CD19 CAR-T treatment.
  • Gannett Co., Inc. GCI fell 6.2% to $2.43.

Now Read This: How To Earn $500 A Month From Nike Stock Following Quarterly Report